Michael Baron's Contact Details

Michael Baron's Company Details

Tang Capital Management, LLC (Tang Capital) is a life sciences-focused investment firm with a strong track record of creating and building successful biopharmaceutical companies. The principal of Tang Capital founded Ardea Biosciences, Inc. in 2006 and served as its director until its acquisition by AstraZeneca PLC in June 2012. The principal of Tang Capital currently serves as Chairman of Heron Therapeutics, Inc. (NASDAQ: HRTX), La Jolla Pharmaceutical Company (NASDAQ: LJPC), and as the Chairman and Chief Executive Officer of Odonate Therapeutics, Inc. (NASDAQ: ODT). Tang Capital manages an investment fund that is the largest shareholder of all three of these companies. Tang Capital currently has offices in San Diego and New York.